跳至主要内容
临床试验/NCT05213585
NCT05213585Unknown1 期

Treatment of Ocular Demodex Infestation With Topical Ivermectin Cream 1%

Helm Vision Group1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年8月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
发起方
入组人数
20
试验地点
1
主要终点
Comparative density of sleeves

研究概览

简要总结

Patients with Demodex infestation of the eyelids will have the sleeves from both eyes cleaned off with microblepharoexfoliation. Afterwards, one eye will be randomly selected for treatment with topical ivermectin 1% cream. The treatment will be repeated on that eye 2 weeks later. Afterwards, the patients will present monthly for photographs of the eyelashes. The photographs will be reviewed by an ophthalmologist outside of our institution who will be blind to which eye was treated and independently grade the amount of sleeves in each eye. The follow-up will be for 6 months after the second treatment.

详细描述

Informed Consent Form and Authorization to Use and Disclose Protected Health Information

Sponsor / Study Title:

Helm Vision Group / "Treatment of Ocular Demodex Infestation with Topical Ivermectin Cream"

Principal Investigator:

(Study Doctor) Craig Helm, MD

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

The outcomes assessor is blind to which eye was treated. This is a single arm study in that only 1 treatment protocol is being tested in one eye and the contralateral eye is being used as the control. Masking of the outcomes assessor is being done to eliminate bias from the treating physician.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Voluntary participation of subjects with moderate to dense sleeves with no allergy to ivermectin and the ability to keep follow-up appointments.

排除标准

  • Patients under 18 years old and those allergic to ivermectin.

研究组 & 干预措施

Treated eyes

Experimental

All participants will have one eye randomly selected for treatment.

干预措施: Ivermectin cream (Drug)

结局指标

主要结局

Comparative density of sleeves

时间窗: Each patient will be followed for 6 months.

The density of sleeves will be clinically assessed and graded by the outcomes assessor

次要结局

  • Comparative assessment of tear osmolarity between treated and untreated eyes(Each patient will be followed for 6 months)

研究者

发起方
Helm Vision Group
申办方类型
Other
责任方
Principal Investigator
主要研究者

Craig J. Helm

Physician

Helm Vision Group

研究点 (1)

Loading locations...

相似试验